Learn More
TARGETMOL CHEMICALS INC BIMIRALISIB 10MG

Supplier: TARGETMOL CHEMICALS INC T226510MG
Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 500 mg and bulk. Please contact Fisher for quotes. Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha beta gamma and delta and to a lesser extent mTOR kinase which may result in tumor cell apoptosis and growth inhibition in cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth survival and resistance to both chemotherapy and radiotherapy. purity: 99%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.